1 Correction to: CNS Drugs https://doi.org/10.1007/s40263-021-00827-8

In the original publication, the following errors were identified in Fig. 1:

1. The structure of felbamate was shown incorrectly (instead of felbamate, cenobamate was shown).

2. The structure of brivaracetam was shown incorrectly (a hydroxyl group was shown instead of a keto group).

In addition, the order of brivaracetam and levetiracetam was incorrect (levetiracetam was developed earlier).

The corrected Fig. 1 is given below.

Fig. 1
figure 1

Chemical structures of clinically approved antiseizure drugs discussed in this review

The original article has been corrected.